| Literature DB >> 26630927 |
Dejan Zurovac1,2,3, Jean-Olivier Guintran4, Wesley Donald5, Esau Naket6, Josephine Malinga7, George Taleo8.
Abstract
BACKGROUND: Vanuatu, an archipelago country in Western Pacific harbouring low Plasmodium falciparum and Plasmodium vivax malaria transmission, has been implementing a malaria case management policy, recommending parasitological testing of patients with fever and anti-malarial treatment for test-positive only patients. A health facility survey to evaluate the health systems readiness to implement the policy and the quality of outpatient management for patients with fever was undertaken.Entities:
Mesh:
Year: 2015 PMID: 26630927 PMCID: PMC4668700 DOI: 10.1186/s12936-015-1017-4
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Fig. 1Map of Vanuatu archipelago and its location in Western Pacific
Health facility and health worker readiness to implement ‘test and treat’ policy
| Health facilities (N = 41) | n | % |
|---|---|---|
| Malaria diagnostic services | ||
| Routinely providing malaria microscopy service | 26 | 63.4 |
| Malaria microscopy service functional on survey days | 20 | 48.8 |
| Malaria RDTs in stock | 40 | 97.6 |
| Any functional diagnostics on survey days (microscopy or RDTs) | 41 | 100 |
| Anti-malarial medicines (non-expired) | ||
| Artemether-lumefantrine (at least one pack in stock) | 39 | 95.1 |
| Artemether-lumefantrine (all 4 packs in stock) | 31 | 75.6 |
| Artesunate suppositories | 30 | 73.2 |
| Artesunate injections | 27 | 65.8 |
| Primaquine tablets | 26 | 63.4 |
| Chloroquine tablets | 40 | 97.6 |
| Quinine tablets | 26 | 63.4 |
| Quinine injections | 20 | 48.8 |
aAll training since 2009 recommended AL and artesunate treatment while only training from 2012 recommended testing of all patients with fever and anti-malarial treatment of only test-positive results. Training prior to 2012 did not provide testing criteria and was ambiguous about interpretation of test-negative results
Health workers’ knowledge about malaria treatment policies and interpretation of RDT results, by training exposure
| Knowledge of treatment policies (correct response in brackets) | Trained (N = 36) | Not trained (N = 31) | All HWs (N = 67) |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| First-line treatment policy for uncomplicated falciparum malaria | |||
| Adults and children above 5 kg [AL] | 32 (88.9) | 24 (77.4) | 56 (83.6) |
| Children below 5 kg [AL] | 22 (61.1) | 17 (54.8) | 39 (58.2) |
| Pregnant women in first trimester [QN] | 10 (27.8) | 2 (6.5) | 12 (17.9) |
| Pregnant women in second & third trimester [AL] | 21 (58.3) | 15 (48.4) | 36 (53.7) |
| First-line treatment policy for uncomplicated vivax malaria | |||
| Adults and children above 4 years [AL + PQ] | 15 (41.7) | 3 (9.7) | 18 (26.9) |
| Children below 4 years [AL]a | 21 (58.3) | 15 (50.0) | 36 (54.6) |
| Pregnant women in first trimester [QN] | 7 (19.4) | 2 (6.5) | 9 (13.4) |
| Pregnant women in second and third trimester [AL] | 17 (47.2) | 11 (35.5) | 28 (41.8) |
| First-line treatment policy for uncomplicated mixed infection (including | |||
| Adults and children above 4 years [AL + PQ] | 9 (25.0) | 2 (6.5) | 11 (16.4) |
| Children below 4 years [AL] | 22 (61.1) | 14 (45.2) | 36 (53.7) |
| Pregnant women in first trimester [QN] | 9 (25.0) | 2 (6.5) | 11 (16.4) |
| Pregnant women in second & third trimester [AL] | 18 (50.0) | 10 (32.3) | 28 (41.8) |
| Pre-referral Rx for suspected severe malaria [AS sup/inj] | 21 (58.3) | 11 (35.5) | 32 (47.8) |
| First-line treatment policy for severe falciparum malaria | |||
| Adults and children above 5 kg [AS inj]a | 11 (31.4) | 4 (12.9) | 15 (22.7) |
| Children below 5 kg [AS inj]a | 5 (14.3) | 3 (9.7) | 8 (12.1) |
| Pregnant women in first trimester [QN inj]b | 8 (22.9) | 4 (13.3) | 12 (18.5) |
| Pregnant women in second & third trimester [AS inj]b | 5 (14.3) | 4 (13.3) | 9 (13.9) |
aOne health worker excluded due to missing response values
bTwo health workers excluded due to missing response values
Fig. 2Health workers’ history-taking practices for patients with fever, by age
Fig. 3Health workers’ clinical examination practices, by age
Malaria testing and adherence to test result
| n | % | 95 % CI | |
|---|---|---|---|
| Patients with fever (N = 226) | |||
| Tested for malaria | 79 | 35.0 | 23.4–48.6 |
| Tested by malaria microscopy | 31 | 13.7 | 6.4–27.1 |
| Tested by malaria RDT | 49 | 21.7 | 11.8–36.4 |
| Patients tested for malaria (N = 79) | |||
| Test-positive | 0 | na | na |
| Treated for malaria | 1 | 1.3 | 0–3.8 |
Predictors influencing performance of malaria test for patients with fever
| Predictors | No. patients | No. tested | OR (95 % CI) | P-value |
|---|---|---|---|---|
|
| ||||
| Health workers’ pre-service training | ||||
| Nurse/nurse aid/other | 111 | 50 (45.1) | 2.40 (1.29–4.50) | 0.006 |
| Doctor/nurse practitioner | 113 | 28 (24.8) | Ref | |
| Health worker received malaria case management traininga | ||||
| Trained | 96 | 46 (47.9) | 2.39 (1.28–4.47) | 0.006 |
| Not trained | 128 | 22 (35.0) | Ref | |
| Patient’s age | ||||
| 5 years and older | 114 | 49 (43.0) | 2.29 (1.23–4.27) | 0.009 |
| Below 5 years | 110 | 29 (26.4) | Ref | |
| Temperature ≥37.5 °C | ||||
| Yes | 37 | 19 (51.4) | 2.99 (1.33–6.71) | 0.008 |
| No | 186 | 59 (31.7) | Ref | |
| Fever main complaint | ||||
| Yes | 202 | 76 (37.6) | 5.34 (1.12–25.45) | 0.036 |
| No | 22 | 2 (9.1) | Ref | |
| Running nose main complaint | ||||
| Absent | 189 | 72 (38.1) | 3.49 (1.24–9.84) | 0.018 |
| Present | 35 | 6 (17.1) | Ref | |
|
| ||||
| Health worker received malaria supervision in past 6 months | ||||
| Yes | 157 | 55 (35.0) | 1.03 (0.57–1.88) | 0.919 |
| No | 67 | 23 (34.3) | Ref | |
| Health worker has access to malaria treatment guideline | ||||
| Yes | 172 | 64 (37.2) | 1.61 (0.81–3.20) | 0.175 |
| No | 52 | 14 (26.9) | Ref | |
| Health worker trained how to perform RDTs | ||||
| Yes | 181 | 63 (34.8) | 1.00 (0.50–2.00) | 0.992 |
| No | 43 | 15 (34.9) | Ref | |
| Health worker has access to RDT job aide | ||||
| Yes | 164 | 57 (34.8) | 0.99 (0.53–1.84) | 0.973 |
| No | 60 | 21 (35.0) | Ref | |
aOnly relevant case management training recommending testing of all fevers for malaria
bSelected predictors of programmatic interest
Dispensing and counselling practices for febrile patients treated with antibiotics
| Dispensing and counselling tasks | <5 years (N = 81) | 5 years and older (N = 81) | All age groups (N = 162) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | 95 % CI | n | % | 95 % CI | n | % | 95 % CI | |
| Explained how to take drugs | 76 | 93.8 | 87.3–97.1 | 77 | 95.1 | 85.5–98.4 | 153 | 94.4 | 90.1–97.0 |
| Advised to complete all doses | 52 | 64.2 | 49.5–76.7 | 59 | 72.8 | 51.7–87.1 | 111 | 68.5 | 52.6–81.1 |
| Weighed | 27 | 33.3 | 18.1–53.1 | 19 | 24.1 | 9.6–48.5 | 46 | 28.8 | 15.2–47.6 |
| Asked to return immediately if sickera | 16 | 19.8 | 10.7–33.5 | 20 | 25.0 | 14.7–39.1 | 36 | 22.4 | 14.9–32.2 |
| Asked to return if fever persistsa | 13 | 16.1 | 8.6–27.9 | 17 | 21.3 | 12.6–33.5 | 30 | 18.6 | 12.3–27.2 |
| First dose given at HF | 6 | 7.4 | 2.6–19.5 | 2 | 2.5 | 0.3–17.3 | 8 | 4.9 | 1.3–16.6 |
| Advised what to do if vomiting | 1 | 1.2 | 0.2–9.6 | 1 | 1.2 | 0.2–9.6 | 2 | 1.2 | 0.3–5.5 |
aDenominator does not include one patient with a missing value response